Abstract
Variation in prescribing costs between general practitioners is well documented. We previously found that frequent general practitioner contact with drug industry representatives was strongly and independently associated with higher prescribing costs. This paper describes the attitudes and behaviour of general practitioners who report seeing drug representatives frequently.
Original language | English |
---|---|
Pages (from-to) | 1178-1179 |
Number of pages | 2 |
Journal | British Medical Journal |
Volume | 326 |
Issue number | 7400 |
DOIs | |
Publication status | Published - 29 May 2003 |